Effectiveness and acceptability of lidocaine spray in reducing perineal pain during spontaneous vaginal delivery: randomised controlled trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16807257.
- Also identified by PMC identifier 1502173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the effectiveness and acceptability of a lidocaine spray in reducing perineal pain during spontaneous vaginal delivery. Randomised controlled trial. Consultant led obstetric unit. 185 women who had a spontaneous vaginal delivery without epidural analgesia. Topically applied local anaesthetic spray (93 women) and placebo spray (92 women). Primary outcome measure was pain during delivery (0-100 scale). The 16 secondary outcome measures included second degree perineal trauma during delivery, trauma of the genital tract, and dyspareunia by two months. Lidocaine spray did not reduce pain during spontaneous vaginal delivery: mean 77 and 72 on a scale of 0-100 in the lidocaine and placebo groups, respectively (difference between means 4.8, 95% confidence interval -1.7 to 11.2). Lidocaine spray may reduce genital tract trauma during delivery, in particular second degree perineal trauma. The intervention was highly acceptable to the women and midwives. Although lidocaine spray applied to the perineum during spontaneous vaginal delivery did not reduce perineal pain, it was acceptable to both the women and the midwives. Current controlled trials ISRCTN99732966 [controlled-trials.com].
Medical subject headings
- Analgesia, Obstetrical
- Anesthetics, Local
- Lidocaine
- Obstetric Labor Complications
- Pain